Visipaque
These highlights do not include all the information needed to use VISIPAQUE safely and effectively. See full prescribing information for VISIPAQUE. VISIPAQUE (iodixanol) injection, for intra-arterial or intra-venous use Initial U.S. Approval: 1996
e9d87b8c-7695-4c0f-8e81-000dedb5f66d
HUMAN PRESCRIPTION DRUG LABEL
May 5, 2023
GE Healthcare Inc.
DUNS: 053046579
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Iodixanol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Iodixanol
Product Details
FDA regulatory identification and product classification information